Víctor H. González

Pegcetacoplan for the treatment of geographic atrophy secondary to age-related macular degeneration (OAKS and DERBY): two multicentre, randomised, double-masked, sham-controlled, phase 3 trials

Jeffrey S. Heier, Eleonora M. Lad, Frank G. Holz et al. · The Lancet · 2023 · 372 citations

Ocular Disease, Ophthalmology, Age-related Diseases +4

The taxonomic impediment: a shortage of taxonomists, not the lack of technical approaches

Michael S. Engel, Luis M. P. Ceríaco, Gimo M. Daniel et al. · Zoological Journal of the Linnean Society · 2021 · 347 citations · Full text

Early and Long-Term Responses to Anti–Vascular Endothelial Growth Factor Therapy in Diabetic Macular Edema: Analysis of Protocol I Data

Víctor H. González, Joanna Campbell, Nancy M. Holekamp et al. · American Journal of Ophthalmology · 2016 · 340 citations · Full text

Efficacy and safety of avacincaptad pegol in patients with geographic atrophy (GATHER2): 12-month results from a randomised, double-masked, phase 3 trial

Arshad M. Khanani, Sunil Patel, Giovanni Staurenghi et al. · The Lancet · 2023 · 263 citations · Full text

Clinical Epidemiology, Clinical Trials, Geographic Atrophy +5

The DA VINCI Study: Phase 2 Primary Results of VEGF Trap-Eye in Patients with Diabetic Macular Edema

V. Diana, Ursula Schmidt‐Erfurth, Víctor H. González et al. · Ophthalmology · 2011 · 252 citations

Diabetic Retinopathy, Vegf Trap-eye, Ocular Disease +7